Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025

タンパク質発現の世界市場予測:タイプ別(大腸菌、哺乳類、酵母、ピキア、昆虫、バキュロウイルス、無細胞)、製品別(試薬、コンピテントセル、機器、サービス)、用途別、エンドユーザー別、地域別

◆タイトル:Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025
◆商品コード:BT 2435
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年5月20日
◆ページ数:174
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥529,650見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はタンパク質発現の世界市場が2020年22億ドルから2025年41億ドルまで、年平均13.2%成長すると予測しています。本調査レポートでは、タンパク質発現の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、システム種類別(原核生物発現システム、哺乳動物細胞発現システム、昆虫細胞発現システム、イーストエクスプレッションシステム、無細胞式発現システム、ALGALベース発現システム)、製品&サービス別(試薬、発現ベクター、コンピテントセル、器具、サービス)、用途別(治療用、工業用、研究用)、エンドユーザー別(製薬&バイオテクノロジー企業、学術研究機関、契約調査組織、その他エンドユーザー)、地域別、競争状況、企業概要などを含め、ご提供いたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・タンパク質発現の世界市場:システム種類別(原核生物発現システム、哺乳動物細胞発現システム、昆虫細胞発現システム、イーストエクスプレッションシステム、無細胞式発現システム、ALGALベース発現システム)
・タンパク質発現の世界市場:製品&サービス別(試薬、発現ベクター、コンピテントセル、器具、サービス)
・タンパク質発現の世界市場:用途別(治療用、工業用、研究用)
・タンパク質発現の世界市場:エンドユーザー別(製薬&バイオテクノロジー企業、学術研究機関、契約調査組織、その他エンドユーザー)
・タンパク質発現の世界市場:地域別
・競争状況
・企業概要

“The protein expression market is projected to grow at a CAGR of 13.2% during the forecast period (2020–2025).”
The global protein expression market size is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2%. The growth of this market is driven majorly by factors such as increasing incidence of chronic diseases, growth in the geriatric population, growing demand for protein biologics, growth in the life science and biopharmaceutical industries, increasing research activities on recombinant based protein expression and availability of funding for protein-based research. Emerging economies are likely to create significant growth opportunities for players in the market. However, the high cost of protein expression reagents and instruments, along with increasing consolidation and high barriers for new entrants, will challenge market growth.

“By product and service, the reagents segment is expected to grow at the highest CAGR during the forecast period.”
Based on product and service, the protein expression market is segmented into reagents, expression vectors, competent cells, instruments, and services. The reagents segment accounted for the largest market share in 2019. This segment is also expected to register the highest growth during the forecast period. The large share of this segment is attributed to the increasing research activities in the field of protein expression and the large-scale production of antibodies and vaccines.

“By system type, the prokaryotic expression systems segment dominated the global protein expression market in 2019.”
Based on system type, the external protein expression market is segmented into prokaryotic expression systems, mammalian cell expression systems, insect cell expression systems, yeast expression systems, cell-free expression systems, and algal-based expression systems. The prokaryotic expression systems segment accounted for the largest share of the global protein expression industry in 2019, owing to low cost and ease of use of prokaryotic expression systems.

“Asia Pacific protein expression market is expected to witness the highest growth during the forecast period.”
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the high incidence of chronic diseases, increasing public and private investments, and an increase in life sciences research.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–29%, Tier 2–37%, and Tier 3–34%
• By Designation: C-level–35%, Director-level–25%, and Others–40%
• By Region: North America–35%, Europe–32%, Asia Pacific–22%, RoW-11%

The prominent players operating in the global protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).

Research Coverage:
The report analyzes the protein expression market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the protein expression industry
• Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the protein expression market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global protein expression industry
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of leading players in the protein expression market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 24)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 33)

4 PREMIUM INSIGHTS (Page No. – 37)
4.1 PROTEIN EXPRESSION MARKET OVERVIEW
4.2 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION & COUNTRY (2019)
4.3 PROTEIN EXPRESSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW (Page No. – 39)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of chronic diseases
5.2.1.2 Growth in the geriatric population
5.2.1.3 Increasing demand for protein biologics
5.2.1.4 Growth in the life science and biopharmaceutical industries
5.2.1.5 Increasing research activities on recombinant-based protein expression
5.2.1.6 Availability of funding for protein-based research
5.2.2 RESTRAINTS
5.2.2.1 High cost of protein expression reagents and instruments
5.2.2.2 Increasing consolidation and high barriers for new entrants
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of microfluidics
5.2.3.2 Emerging economies offer significant growth potential
5.2.4 CHALLENGES
5.2.4.1 Contamination—A major challenge in protein purification
5.2.4.2 Complexities associated with membrane protein expression and purification
5.3 THE IMPACT OF COVID-19 OUTBREAK ON THE GROWTH OF THE PROTEIN EXPRESSION MARKET
5.3.1 VACCINE AND THERAPY DEVELOPMENT FOR COVID-19 TO BOOST THE MARKET FOR PROTEIN EXPRESSION SYSTEMS
5.3.2 INCREASING RESEARCH TO IDENTIFY IDEAL TARGET PROTEINS ON SARS-COV-2 FOR DEVELOPING THERAPIES AS WELL AS DIAGNOSTIC TESTS
5.3.3 LOGISTIC CHALLENGES DUE TO SARS-COV-2 MAY RESULT IN DELAY IN PROTEIN EXPRESSION RESEARCH
5.3.4 EFFECT OF COVID-19 ON THE PHARMACEUTICAL INDUSTRY
5.3.5 PHARMA & BIOTECH COMPANIES ARE DECREASING THEIR DEPENDENCY ON CHINA BY MOVING THEIR MANUFACTURING FACILITIES FROM CHINA TO OTHER PARTS OF THE WORLD
5.3.6 INCREASE IN GOVERNMENT FUNDING

6 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE (Page No. – 50)
6.1 INTRODUCTION
6.2 PROKARYOTIC EXPRESSION SYSTEMS
6.2.1 ESCHERICHIA COLI SYSTEMS
6.2.1.1 Increasing use of E. coli systems for the production of commercial proteins to support market growth
6.2.2 OTHER PROKARYOTIC EXPRESSION SYSTEMS
6.3 MAMMALIAN CELL EXPRESSION SYSTEMS
6.3.1 CHINESE HAMSTER OVARY SYSTEMS
6.3.1.1 Chinese hamster ovary systems account for the largest share of the mammalian expression systems market
6.3.2 OTHER MAMMALIAN CELL SYSTEMS
6.4 INSECT CELL EXPRESSION SYSTEMS
6.4.1 BACULOVIRUS SYSTEMS
6.4.1.1 Baculovirus systems show high yield and expression level, especially for intracellular proteins
6.4.2 OTHER INSECT CELL SYSTEMS
6.5 YEAST EXPRESSION SYSTEMS
6.5.1 K. LACTIS SYSTEMS
6.5.1.1 K. lactis systems held the largest share of the yeast expression systems market in 2019
6.5.2 SACCHAROMYCES SYSTEMS
6.5.2.1 Saccharomyces systems channelize the direction of foreign proteins into secretory pathways using various signals
6.5.3 PICHIA SYSTEMS
6.5.3.1 Pichia systems are used for the production of antifreeze proteins and lytic enzymes
6.5.4 OTHER YEAST EXPRESSION SYSTEMS
6.6 CELL-FREE EXPRESSION SYSTEMS
6.6.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS WILL DRIVE THE GROWTH OF THIS SEGMENT
6.7 ALGAL-BASED EXPRESSION SYSTEMS
6.7.1 GROWTH IN THE VACCINES MARKET IS SUPPORTING THE GROWTH OF THIS SEGMENT

7 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE (Page No. – 63)
7.1 INTRODUCTION
7.2 REAGENTS
7.2.1 REAGENTS ARE THE LARGEST AND FASTEST-GROWING PRODUCTS IN THE PROTEIN EXPRESSION MARKET
7.3 EXPRESSION VECTORS
7.3.1 EXPRESSION VECTORS ARE FREQUENTLY USED DURING TRANSFECTION
7.4 COMPETENT CELLS
7.4.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET GROWTH
7.5 INSTRUMENTS
7.5.1 INSTRUMENTS HELP IN THE EFFICIENT TRANSFER OF GENETIC MATERIALS INTO HOST CELLS
7.6 SERVICES
7.6.1 RISING DEMAND FOR CUSTOMIZED PROTEINS TO DRIVE THE MARKET FOR SERVICES

8 PROTEIN EXPRESSION MARKET, BY APPLICATION (Page No. – 69)
8.1 INTRODUCTION
8.2 THERAPEUTIC APPLICATIONS
8.2.1 THERAPEUTIC PROTEINS ARE USED TO TREAT PATHOLOGICAL CONDITIONS
8.3 INDUSTRIAL APPLICATIONS
8.3.1 RAPID GROWTH IN THE INDUSTRIAL ENZYMES MARKET IS AN IMPORTANT DRIVER FOR THE GROWTH OF THIS SEGMENT
8.4 RESEARCH APPLICATIONS
8.4.1 INCREASING INVESTMENTS IN RESEARCH ACTIVITIES WILL DRIVE THE GROWTH OF THIS APPLICATION SEGMENT

9 PROTEIN EXPRESSION MARKET, BY END USER (Page No. – 74)
9.1 INTRODUCTION
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PROTEIN EXPRESSION SYSTEMS
9.3 ACADEMIC RESEARCH INSTITUTES
9.3.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET GROWTH
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.4.1 INCREASING CLINICAL TRIALS AND OUTSOURCING OF PHARMACEUTICAL MANUFACTURING WILL DRIVE MARKET GROWTH
9.5 OTHER END USERS

10 PROTEIN EXPRESSION MARKET, BY REGION (Page No. – 79)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 The US dominates the global protein expression market
10.2.2 CANADA
10.2.2.1 Government funding for research and innovation to support market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Germany is the largest market for protein expression in Europe
10.3.2 FRANCE
10.3.2.1 Proteomics research in France is strongly supported by the government
10.3.3 UK
10.3.3.1 Surge in the prevalence of chronic diseases will drive market growth
10.3.4 ITALY
10.3.4.1 Growth in this market is driven by the increase in life sciences research projects
10.3.5 SPAIN
10.3.5.1 Spain has an established network of research centers, universities, and hospitals
10.3.6 REST OF EUROPE (ROE)
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Growth in R&D to enhance technological capabilities in the country
10.4.2 JAPAN
10.4.2.1 Rising geriatric population to support market growth
10.4.3 INDIA
10.4.3.1 Increasing investments in proteomics research to support market growth
10.4.4 AUSTRALIA
10.4.4.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities in Australia
10.4.5 REST OF ASIA PACIFIC (ROAPAC)
10.5 REST OF THE WORLD (ROW)
10.5.1 LATIN AMERICA
10.5.1.1 Increasing research in the field of stem cells to support market growth in Latin America
10.5.2 MIDDLE EAST & AFRICA
10.5.2.1 Government investments in the healthcare sector and growing pharmaceuticals industry to drive market growth in the region

11 COMPETITIVE LANDSCAPE (Page No. – 127)
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING COMPANIES
11.4 COMPETITIVE SCENARIO
11.4.1 KEY DEVELOPMENTS IN THE PROTEIN EXPRESSION MARKET

12 COMPANY PROFILES (Page No. – 133)
(Business overview, Products and Services offered, Recent developments, SWOT analysis, MNM view)*
12.1 THERMO FISHER SCIENTIFIC, INC.
12.2 MERCK KGAA
12.3 GENSCRIPT BIOTECH CORPORATION
12.4 AGILENT TECHNOLOGIES, INC.
12.5 TAKARA BIO, INC.
12.6 BIO-RAD LABORATORIES, INC.
12.7 LONZA
12.8 PROMEGA CORPORATION
12.9 NEW ENGLAND BIOLABS
12.11 OXFORD EXPRESSION TECHNOLOGIES LTD.
12.11 LIFESENSORS
12.12 PROTEOGENIX
12.13 SYNTHETIC GENOMICS, INC. (SGI)
12.14 PEAK PROTEINS LTD.
12.15 PROMAB BIOTECHNOLOGIES, INC.
12.16 SINO BIOLOGICAL, INC.
12.17 LUCIGEN CORPORATION.
12.18 ARTES BIOTECHNOLOGY GMBH
12.19 JENA BIOSCIENCE GMBH
12.20 BIONEER CORPORATION
12.21 LENIOBIO GMBH

*Business overview, Products and Services offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.



★調査レポート[タンパク質発現の世界市場予測:タイプ別(大腸菌、哺乳類、酵母、ピキア、昆虫、バキュロウイルス、無細胞)、製品別(試薬、コンピテントセル、機器、サービス)、用途別、エンドユーザー別、地域別] ( Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025 / BT 2435) 販売に関する免責事項
[タンパク質発現の世界市場予測:タイプ別(大腸菌、哺乳類、酵母、ピキア、昆虫、バキュロウイルス、無細胞)、製品別(試薬、コンピテントセル、機器、サービス)、用途別、エンドユーザー別、地域別] ( Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025 / BT 2435) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆